Related Experiment Video
Updated: Jul 25, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
Assessment and treatment of depression following myocardial infarction
T P Guck1, M G Kavan, G N Elsasser
1Department of Family Practice, Creighton University School of Medicine, Omaha, Nebraska 68124, USA. tpguck@creighton.edu
Insights
Depression significantly impacts cardiovascular health, increasing mortality risk by 3.5 times in patients with existing heart disease. Early detection and treatment with cognitive-behavior therapy and SSRIs are crucial for better outcomes.
Area of Science:
- Cardiology
- Psychiatry
- Clinical Medicine
Background:
- Depression affects a significant portion of acute myocardial infarction patients.
- Major depression is a prevalent comorbidity in cardiovascular disease patients.
- Depression is an independent risk factor for cardiovascular disease development and mortality.
Purpose of the Study:
- To highlight the prevalence of depression in acute myocardial infarction patients.
- To emphasize the increased mortality risk associated with depression in cardiovascular disease.
- To outline recommended assessment and treatment strategies for depression in cardiovascular patients.
Main Methods:
- Physicians can utilize self-report inventories like SIG E CAPS + mood mnemonic for depression screening.
- Cognitive-behavior therapy (CBT) is identified as a preferred psychologic treatment.
- Selective serotonin reuptake inhibitors (SSRIs) are recommended pharmacologic treatments due to their cardiovascular safety profile.
Main Results:
- Depressed individuals with cardiovascular disease face a 3.5-fold higher risk of death compared to non-depressed individuals.
- SSRIs are favored for pharmacologic treatment due to minimal cardiovascular side effects.
- Combined treatment of SSRIs and CBT often yields the most effective results for this patient group.
Conclusions:
- Prompt assessment and management of depression are vital for improving outcomes in cardiovascular disease patients.
- A combination of pharmacologic (SSRIs) and psychologic (CBT) interventions offers the most effective treatment approach.
- Addressing depression in cardiovascular patients can mitigate mortality risk and enhance overall prognosis.
Abstract:
Approximately 65 percent of patients with acute myocardial infarction report experiencing symptoms of depression. Major depression is present in 15 to 22 percent of these patients. Depression is an independent risk factor in the development of and mortality associated with cardiovascular disease in otherwise healthy persons. Persons who are depressed and who have pre-existing cardiovascular disease have a 3.5 times greater risk of death than patients who are not depressed and have cardiovascular disease. Physicians can assess patients for depression by using one of several easily administered and scored self-report inventories, including the SIG E CAPS + mood mnemonic. Cognitive-behavior therapy is the preferred psychologic treatment. Selective serotonin reuptake inhibitor antidepressants are the recommended pharmacologic treatment because of the relative absence of effects on the cardiovascular system. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment for depression in patients with cardiovascular disease.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

